Jurimatic by Exlitem

Amgen Inc. Hit with $50.3M Verdict for Infringement of Patented Cancer Immunotherapy Method

Amgen Inc. Hit with $50.3M Verdict for Infringement of Patented Cancer Immunotherapy Method

N
Nishica Srivastava
January 8, 2025
Amgen Inc. Hit with $50.3M Verdict for Infringement of Patented Cancer Immunotherapy Method
Amgen Inc. Hit with $50.3M Verdict for Infringement of Patented Cancer Immunotherapy Method

Lindis Biotech, Gmbh V. Amgen Inc.

Case Background

Lind

...

Continue Reading This Article

Subscribe to access this article and our entire library of legal content.

Unlimited access to all articles
Expert legal analysis and insights
Downloadable resources and templates
Subscribe Now Login to Access

You've reached your free article limit for this month

Tags

patent infringement
cancer treatment
patented immunotherapy regimen
willful